Bristol-Myers to sell blockbuster Otezla for its $74 billion merger with Celgene Medical Dialogues Bureau26 Jun 2019 9:00 AM ISTBristol-Myers announced its plans to buy Celgene in a cash-and-stock deal in early January to bring together the companies that specialize in oncology...
Sanofi, Google team up to discover better treatments Medical Dialogues Bureau23 Jun 2019 9:05 AM ISTSanofi and Google will use data sets to improve their understanding of key diseases and extract patients' insights and feedback, the companies said in...
Roche gets USFDA nod for combo lymphoma treatment Polivy Medical Dialogues Bureau11 Jun 2019 9:30 AM ISTPolivy was approved in combination with Roche's older drug Rituxan and a chemotherapy agent for adult patients with advanced diffuse large B-cell...
Mediclaim cannot be denied on presumption of pre-existing disease: NCDRC Medical Dialogues Bureau9 Jun 2019 11:15 AM ISTThe commission also said in its view, diabetes was a lifestyle disease in India and the whole insurance claim (Mediclaim) cannot be rejected only...
Roche, GE Healthcare launch NAVIFY Tumor Board to enable personalised treatment decisions in cancer care Medical Dialogues Bureau3 Jun 2019 9:45 AM ISTThe new version of NAVIFY Tumor Board is initially available in the United States and Canada with additional markets to follow in the near future.New...
Granules India gets USFDA nod for Methylphenidate Hydrochloride ER capsules Farhat Nasim28 May 2019 10:00 AM ISTThe approved product, Methylphenidate Hydrochloride extended-release capsules, is bioequivalent to the reference listed drug product (RLD), Ritalin LA...
Pfizer epilepsy drug Lyrica fails in phase III trial Medical Dialogues Bureau28 May 2019 9:00 AM ISTNew Delhi: Pfizer Inc. recently announced that a Phase 3 study to assess the use of LYRICA (pregabalin) as adjunctive therapy for epilepsy patients 5...
Roche gets USFDA nod for combo drug Venclexta, Gazyva to treat lymphocytic leukaemia Medical Dialogues Bureau17 May 2019 9:15 AM IST"Venclexta plus Gazyva is the only chemotherapy-free option of fixed duration that provides durable responses to help people live longer without...
Eli Lilly gets USFDA nod for Cyramza to treat hepatocellular carcinoma Medical Dialogues Bureau14 May 2019 9:47 AM ISTThe USFDA has removed the boxed warning from the CYRAMZA labelling which highlighted warnings pertaining to haemorrhage, gastrointestinal perforation...
Pfizer acquires clinical-stage Biotech Therachon for $810 million Garima12 May 2019 9:45 AM ISTNEW YORK: Pfizer recently announced that it has entered into a definitive agreement to acquire all the shares of Therachon Holding AG, a privately...
AstraZeneca, Daiichi Sankyo breast cancer drug Trastuzumab Deruxtecan shows promise Medical Dialogues Bureau10 May 2019 9:00 AM ISTThe treatment Trastuzumab Deruxtecan, or DS-8201, demonstrated a clinically meaningful response in patients with refractory HER2-positive metastatic...
AbbVie wins USFDA nod for Mavyret to treat HCV genotypes in pediatric patients Farhat Nasim3 May 2019 9:10 AM ISTNew Delhi: AbbVie Inc. recently won the U.S. Food and Drug Administration (USFDA) approval for Mavyret (glecaprevir and pibrentasvir) tablets to treat...
